Skip to content

The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews

The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03938428
Acronym
PEPPR
Enrollment
132
Registered
2019-05-06
Start date
2019-07-24
Completion date
2020-06-30
Last updated
2019-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accidental Fall, Allied Health Personnel, Pharmaceutical Preparations

Brief summary

This study seeks to understand how patients feel about their medicines before and after receiving a clinical medication review.

Detailed description

Falls in people aged 65 years and over are a common reason for calling the emergency ambulance service. Falls can be serious, with about 1 in 20 people having to be taken to hospital because they have been injured. Thankfully, in more than 4 out of 10 cases, people are not seriously injured and can be left at home. However, it is important that the reason for the fall is found and future falls are prevented where possible. Yorkshire Ambulance Service can already make a referral to another local service to get specialist practical help for falls prevention when people are left at home after a fall. Research has shown that the safe use of medicines can prevent future falls, but that did not form. Now a new service has been set up for Yorkshire Ambulance Service to refer patients to the Leeds GP Confederation. A pharmacist working in the patients GP surgery will undertake a review of the patient's use of their medicines. We would like to find out about how patients feel about using their medicines before and after the medicines review by a pharmacist. We would also like to know how they feel about the medicines review itself, to help decide whether this scheme should continue or be expanded to other areas. To do this, we are going to send a questionnaire to patients who receive a medicines review. The questionnaire will be sent by post, take about 10 minutes to fill out and include a stamped addressed envelope so people who take part will not have to pay for postage.

Interventions

OTHERSurvey

Patients who are eligible for this study will have been previously identified as part of the PREFACES project. The pharmacist who has conducted the clinical medication review will obtain verbal permission from the patient to be contacted by the research study team. This will be documented on the referral outcome document that is returned to the YAS clinical team. A member of YAS clinical staff from the PREFACES project will forward the name and residential address of patients who have agreed to be contacted to the research paramedic for this study. A covering letter, participant information sheet, questionnaire and consent form, will be posted to potential participants. A stamped addressed envelope will be included to enable return of the completed booklet at no costs to participants.

Sponsors

NIHR Yorkshire and Humber Patient Safety Translational Research Centre
CollaboratorUNKNOWN
Yorkshire Ambulance Service NHS Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* Received a pharmacist-led clinical medication review following a falls referral made by a paramedic from Yorkshire Ambulance * Registered with a GP in the Leeds area * Has capacity to consent to take part in the study

Exclusion criteria

* Did not receive a pharmacist-led clinical medication review after a Yorkshire Ambulance Service paramedic made a falls referral * Not registered with a GP in the Leeds area * Does not have capacity to consent to take part in the study

Design outcomes

Primary

MeasureTime frame
Proportion of patients who express a change in emotion relating to how they feel about their medicines, following a pharmacist-led clinical medication review.1 month

Secondary

MeasureTime frame
Patient expressed emotion1 month

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026